## PNC: PNC Financial Services Group, I - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 2.6% below STRENGTH zone (4.0-10.0%); PEG 1.94 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($184.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. PNC Financial Services Group Inc. Takes $184,000 Position in NPK International Inc. $NPKI**
- Source: MarketBeat | 20251129T132215 | Somewhat-Bullish | Relevance: 98%
- PNC Financial Services Group Inc. recently acquired a new stake of 21,579 shares in NPK International Inc., valued at approximately $184,000 during Q2. This acquisition contributes to institutional ownership of 80.81% of NPK International's stock. Analysts currently rate NPK International as a "Moderate Buy" with an average price target of $14.17, with some firms boosting their price targets.

**2. Is PNC Financial Stock Underperforming the S&P 500?**
- Source: Markets Financial Content | 20251201T134000 | Neutral | Relevance: 96%
- PNC Financial Services Group (PNC) is underperforming the S&P 500, with its shares falling 11.8% from its 52-week high and lagging the index over various timeframes. Despite reporting better-than-expected Q3 2025 EPS and revenues, investor concerns over weak core lending operations caused a stock drop. Analysts, however, maintain a "Moderate Buy" rating with a price target significantly above current levels.

**3. PNC Financial Services Group Inc. Boosts Stock Holdings in Impinj, Inc. $PI**
- Source: MarketBeat | 20251129T093644 | Somewhat-Bullish | Relevance: 94%
- PNC Financial Services Group Inc. significantly increased its stake in Impinj, Inc. by 410.1% in Q2, bringing its total holdings to 1,969 shares valued at $219,000. This move reflects broader institutional interest, with other major funds like UBS AM and Ameriprise also boosting their positions, despite insider selling and mixed analyst signals. The article details recent analyst price target increases and insider trading activity for Impinj.

**4. PNC Financial Services Group Inc. Makes New $228,000 Investment in BeOne Medicines Ltd. - Sponsored ADR $ONC**
- Source: MarketBeat | 20251129T095226 | Somewhat-Bullish | Relevance: 93%
- PNC Financial Services Group Inc. has made a new investment of $228,000 in BeOne Medicines Ltd. - Sponsored ADR ($ONC), acquiring 940 shares valued in the second quarter. This move comes as several other institutional investors also increased their holdings in BeOne Medicines, with the stock currently having a "Moderate Buy" consensus rating and an average target price of $365.79 from analysts. Despite analyst optimism, company insiders have sold a significant amount of stock recently, totaling over $27.97 million in the past 90 days.

**5. PNC Financial Services Group Inc. Invests $265,000 in Pursuit Attractions and Hospitality, Inc. $PRSU**
- Source: MarketBeat | 20251129T020652 | Somewhat-Bullish | Relevance: 92%
- PNC Financial Services Group Inc. has invested $265,000 in Pursuit Attractions and Hospitality, Inc. ($PRSU), acquiring 9,197 shares in Q2. This comes amidst other institutional investments and insider buying, with CEO David W. Barry increasing his holdings. Pursuit reported strong quarterly EPS, a high net margin, and holds a "Moderate Buy" analyst rating.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-19 | Oppenheimer | $231 | $240 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-19 | Oppenheimer | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.17M) |
| Sells | 3 ($0.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.1%)
- Blackrock Inc.: 8.1% (-4.9%)
- State Street Corpora: 4.4% (+0.5%)
- FMR, LLC: 4.1% (+0.8%)
- Capital Internationa: 2.8% (+6.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.94 elevated, pricing in significant growth expectations. Forward P/E 10.9x attractive for 11% earnings growth. Quality metrics strong (margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $81.3B |
| Beta | 1.01 |
| 52W Range | $145.12 - $208.80 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.94 |
| Forward P/E | 10.9 |
| Current P/E | 12.1 |
| YoY Growth | 11.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.9% to 2.6% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. AM_20 at 3.7% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.37), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.61% (CS: 77) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 1.37 | Bullish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.021x | Above |
| vs SMA200 | 1.047x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $192.40
- **Stop Loss:** $184.80 (4.0% risk)
- **Target:** $200.00 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 131
- **Position Value:** $25,204.40
- **Portfolio %:** 25.20%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-16 (Est: $4.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.04 | $4.35 | +7.6% |
| 2025Q2 | $3.55 | $3.85 | +8.5% |
| 2025Q1 | $3.38 | $3.51 | +4.0% |
| 2024Q4 | $3.35 | $3.77 | +12.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*